Treatment algorithm for newly diagnosed T2DM\
\
HbA1c <6.5% AND FPG <6.0 mmol/L\
•	Consider metformin monotherapy (only one form of medication)\
•	if post prandial is > 11.0 mmol/L and/or metformin not tolerated, use:\
    o	Meglitinide\
    o	AGI (αa-glucosidase inhibitor)\
    o	DPP4-i (DPP4-inhibitors)\
\
HbA1c 6.5-7.4% OR FPG 6.0-7.9 mmol/L\
•	Mono or dual therapy with\
    o	Metformin OR\
    o	SU (Sulphonylureas)\
    o	DPP4-i\
    o	SGLT2-i (SGLT2-inhibitors)\
\
HbA1c 7.5-8.4% OR FPG 8.0-9.9 mmol/L\
•	Dual combination therapy with any combination of:\
    o	Metformin \
    o	SU \
    o	Meglitinide \
    o	AGI \
    o	TZD (Thiazolidinedione)\
    o	DPP4-i \
    o	GLP1-RA \
    o	SGLT2-i \
    o	Insulin\
\
HbA1c 8.5-10.0% OR FPG 10.0-13.0 mmol/L\
•	Triple combination therapy with any combination of:\
    o	Metformin \
    o	SU \
    o	Meglitinide \
    o	AGI \
    o	TZD \
    o	DPP4-i \
    o	GLP1-RA\
    o	SGLT2-i \
    o	Insulin\
\
HbA1c >10.0% OR FPG >13.0 mmol/L\
•	Basal/premixed insulin therapy + Combination therapy\
            or\
•	Intensive insulin therapy + OGLD\